These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2065276)

  • 21. [Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy].
    Orcajo Rincón J; Alonso Farto JC; Rotger Regi A; Hernández Pérez R; Hualde AM; Pérez Aradas V
    Rev Esp Med Nucl; 2011; 30(5):307-10. PubMed ID: 21641092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.
    Kao SC; McCaughan B; Muljono A; Boyer M
    J Thorac Oncol; 2010 Mar; 5(3):405-6. PubMed ID: 20186029
    [No Abstract]   [Full Text] [Related]  

  • 24. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
    de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
    Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma.
    Metintas M; Ozdemir N; Uçgun I; Elbek O; Kolsuz M; Mutlu S; Metintas S
    Chest; 1999 Aug; 116(2):391-8. PubMed ID: 10453867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
    Berghmans T; Lafitte JJ; Paesmans M; Stach B; Berchier MC; Wackenier P; Lecomte J; Collon T; Mommen P; Sculier JP;
    Lung Cancer; 2005 Oct; 50(1):75-82. PubMed ID: 16005104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemetrexed-cisplatin combination in mesothelioma.
    Reck M; Gatzemeier U
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients.
    Hastürk S; Tastepe I; Unlü M; Cetin G; Baris YI
    J Chemother; 1996 Apr; 8(2):159-64. PubMed ID: 8708749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
    Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112.
    Muers MF; Rudd RM; O'Brien ME; Qian W; Hodson A; Parmar MK; Girling DJ;
    Thorax; 2004 Feb; 59(2):144-8. PubMed ID: 14760156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
    Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
    Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
    Rusch VW
    J Clin Oncol; 2003 Jul; 21(14):2629-30. PubMed ID: 12860935
    [No Abstract]   [Full Text] [Related]  

  • 33. Complete response and long-term survival in malignant pleural mesothelioma: case report.
    Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
    Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma.
    Shimokawa M; Hasegawa S; Fukuoka K; Okada M; Yokoi K; Tanaka F; Yamanaka T; Daimon T; Nakano T
    Jpn J Clin Oncol; 2013 May; 43(5):575-8. PubMed ID: 23509402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
    Samuels BL; Herndon JE; Harmon DC; Carey R; Aisner J; Corson JM; Suzuki Y; Green MR; Vogelzang NJ
    Cancer; 1998 Apr; 82(8):1578-84. PubMed ID: 9554537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: in vitro experiments and clinical application.
    Tagawa T; Yoshino I; Yamaguchi M; Osoegawa A; Kameyama T; Fukuyama S; Kometani T; Maehara Y
    Surg Today; 2006; 36(2):135-9. PubMed ID: 16440159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of alternating chemotherapy with 2 non-cross-resistant drug combinations on human alimentary and breast cancer xenografts in nude mice].
    Fujita F; Fujita M; Yamauchi T; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1297-304. PubMed ID: 2953311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
    Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
    J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A diffuse, pleural, malignant mesothelioma kept in long remission by chemotherapy combining pirarubicin and cisplatin].
    Niki Y; Soga T; Nishimura A; Kato M; Hamada M; Kanamaru M
    Gan No Rinsho; 1990 Nov; 36(14):2463-7. PubMed ID: 2250368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.